NAVIDEA BIOPHARMACEUTICALS, INC.·4

Feb 19, 4:50 PM ET

Cope Frederick O 4

4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Feb 19, 2013

Insider Transaction Report

Form 4
Period: 2013-02-15
Cope Frederick O
Vice President
Transactions
  • Award

    Stock Option (Right to Buy)

    2013-02-15+145,000145,000 total
    Exercise: $3.08Exp: 2023-02-15Common Stock (145,000 underlying)
Footnotes (1)
  • [F1]Option vests 25% per year beginning on the first anniversary of the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary